{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-042204","form_type":"8-K","ticker":"MBOT","cik":"0000883975","company_name":"Microbot Medical Inc.","filed_at":"2023-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.242522+00:00","generated_at":"2026-06-07T23:06:01.688170+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Microbot Medical appoints Dr. Juan Diaz-Cartelle as CMO effective Dec 1, 2023","bullets":["Dr. Diaz-Cartelle was previously Senior Medical Director at Boston Scientific (14 yrs) and Executive Medical Director at Haemonetics.","Base salary $350,000, target bonus up to 30% of salary, and 25,000 stock options vesting over three years.","He will lead U.S. clinical trials for the LIBERTY Endovascular Robotic Surgical System and FDA regulatory process.","Succeeds Dr. Eyal Morag; company shifts focus from R&D in Israel to U.S.-based clinical and commercial activities."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-042204","json":"https://secwatch.observer/filing/0001493152-23-042204.json","markdown":"https://secwatch.observer/filing/0001493152-23-042204.md","text":"https://secwatch.observer/filing/0001493152-23-042204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883975/000149315223042204/0001493152-23-042204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883975/000149315223042204/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T23:06:01.688170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f8a11f9564","claim":"Dr. Juan Diaz-Cartelle was appointed as Chief Medical Officer at Microbot Medical Inc..","evidence_excerpt":"On November 21, 2023, Microbot Medical Inc. (the “Company”) announced the appointment of Dr. Juan Diaz-Cartelle, age 48, as the Company’s new Chief Medical Officer (“CMO”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223042204/0001493152-23-042204-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}